Skip to search formSkip to main contentSkip to account menu

PI3K/mTOR Inhibitor LY3023414

Known as: LY 3023414, LY-3023414, LY3023414 
An orally bioavailable, small molecule inhibitor of certain class I phosphoinositide 3-kinase (PI3K) isoforms and mammalian target of rapamycin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The dual PI3K/mTOR inhibitor LY3023414 also displayed moderate single-agent activity in this study of patients with heavily…